Prenatal screening for carriers of cystic fibrosis should screen both partners individually

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7060.820b (Published 28 September 1996) Cite this as: BMJ 1996;313:820
  1. Marc De Braekeleer, Professor
  1. Cystic Fibrosis Research Laboratory, Departement des Sciences Humaines, Universite du Quebec a Chicoutimi, Chicoutimi, Quebec G7H 2B1, Canada

    EDITOR,—Screening of pregnant women for mutations in the transmembrane conductance regulator gene for cystic fibrosis is under way in several regions. During the past few years, several papers have been published about such screening, which causes problems.1 2

    On the basis of a carrier frequency of 4% in the general population and a feasible rate of detection of mutations of 85%, one can calculate the proportion of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription